Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Histamine as a Molecular Transducer of Adaptation to Exercise [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 clinical trial update exploring histamine as a molecular mediator of adaptation to exercise in individuals with postexercise hypotension; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oregon | Conditions: Postexercise Hypotension | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING